|
Evotec opts for Genedata
August 2016
SHARING OPTIONS:
BASEL, Switzerland—Evotec AG has selected Genedata Screener as a data
management platform solution for its drug discovery work, Genedata reported last month. Evotec
applies the platform for high-content screening and high-throughput screening operations, and Screener also enables screening technologies such as surface
plasmon resonance, thermal shift analysis, compound combinations, HT-flow, ion channel and profiling.
“Genedata
Screener has become the software of choice for screening data analysis in pharma and bio-pharma industries,” Dr. Othmar Pfannes, CEO of Genedata, said
in a press release. “Therefore, we’re seeing increased Screener adoption by leading CROs, such as Evotec, who see quantifiable value in using the
same data analysis methodology used by their customers. Genedata is committed to increasing that value by investing in our software so that it continually
keeps pace with new business concepts, technologies and workflows as they arise.”
Back |
Home |
FAQs |
Search |
Submit News Release |
Site Map |
About Us |
Advertising |
Resources |
Contact Us |
Terms & Conditions |
Privacy Policy
|